唯捷創芯(688153.SH):在AI設備領域採取了多元化的合作模式
格隆匯5月22日丨唯捷創芯(688153.SH)在互動平臺表示,目前,公司在AI設備領域採取了多元化的合作模式,以確保我們的射頻解決方案能夠廣泛覆蓋市場。一方面,我們已與多家終端客戶展開深入溝通,並有多個項目正在落地。這些直接合作項目使我們能夠深入瞭解終端客戶的具體需求,提供定製化的射頻解決方案,確保產品性能與客戶需求高度匹配。另一方面,我們也積極開展了與模組廠商的合作,進而爲更廣泛的AI設備製造商提供支持。這種合作模式不僅擴大了我們的市場覆蓋範圍,還提升了我們產品的通用性和靈活性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.